what two drugs are in glyxambi
With GLYXAMBI, the dual inhibition of DPP-4 and SGLT2 â two proven targets in the treatment of type 2 diabetes â now provides U.S. physicians and patients with an option to simultaneously address multiple pathways to improve glycemic control.